(Q36892327)

16 August 2017

1 reference

title

Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications? (English)

1 reference

16 August 2017

H Kuhl

1

1 reference

16 August 2017

I Wiegratz

series ordinal

2

1 reference

16 August 2017

publication date

1 August 2007

1 reference

16 August 2017

1 reference

16 August 2017

volume

10

1 reference

16 August 2017

issue

4

1 reference

16 August 2017

page(s)

344-353

1 reference

Pharmacology of estrogens and progestogens: influence of different routes of administration

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Formation of 7 alpha-methyl-ethinyl estradiol during treatment with tibolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Conversion of tibolone to 7alpha-methyl-ethinyl estradiol using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry: interpretation and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Pharmacokinetics of tibolone in early and late postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Aromatase inhibitors in the treatment of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Aromatase--a brief overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

The in vivo human metabolism of tibolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

In vivo conversion of norethisterone and norethisterone acetate to ethinyl etradiol in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Tibolone is not converted by human aromatase to 7alpha-methyl-17alpha-ethynylestradiol (7alpha-MEE): analyses with sensitive bioassays for estrogens and androgens and with LC-MSMS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Lack of aromatisation of the 3-keto-4-ene metabolite of tibolone to an estrogenic derivative.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Progestogen-only contraception in women at high risk of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Estrogenic effects of 7alpha-methyl-17alpha-ethynylestradiol: a newly discovered tibolone metabolite

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

LIFT study is discontinued

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Endometrial cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Tibolone and endometrial cancer: a cohort and nested case-control study in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Endometrial cancer and hormone-replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Tibolone and risk of endometrial polyps: a prospective, comparative study with hormone therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

A physiologic role for testosterone in limiting estrogenic stimulation of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Breast cancer and hormone-replacement therapy in the Million Women Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

A comparison of the potencies and activities of progestogens used in contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

The effect of tibolone on the lipoprotein profile of postmenopausal women with type III hyperlipoproteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

Type III Hyperlipoproteinemia: Paradoxical Hypolipidemic Response to Estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F13697130701380434

10.1080/13697130701380434

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference